Literature DB >> 2973067

CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.

J A Ledbetter1, N K Tonks, E H Fischer, E A Clark.   

Abstract

Evidence is presented that the leukocyte common antigen CD45 can regulate both signal transduction by lymphocyte receptor molecules and T- and B-cell proliferation in a manner dependent on specific interactions between these receptors on the cell surface. Formation of homoaggregates of CD3, CD2, or CD28 on the surface of T cells induced by crosslinking with monoclonal antibodies (mAbs) results in an increase in cytoplasmic free calcium concentration ([Ca2+]i). This increase in [Ca2+]i was abolished when these receptors were crosslinked to CD45 on the cell surface. In contrast, the increase in [Ca2+]i induced by formation of homoaggregates of CD4 was strongly amplified when CD4 was coupled to CD45. T-cell proliferation initiated by immobilized anti-CD3 was inhibited by anti-CD45 or anti-CD45R when immobilized on the same surface, but not when in solution. Similarly, proliferation after stimulation of the CD2 and CD28 receptors was inhibited when a CD45 mAb was crosslinked to either CD2 or CD28 mAbs, but not when a CD45-specific mAb was bound to the cell surface separately. In B cells, the increase in [Ca2+]i and resulting proliferation induced by crosslinking either the CD19 or Bgp95 receptors was inhibited by coupling these molecules to CD45. Thus, CD45 appears to modify other cellular receptors functionally when brought into close physical association with them. The homology of the CD45 conserved cytoplasmic domains with a major human placental protein tyrosine phosphatase suggests that the effects of CD45 described here result from alterations in the phosphorylation state of tyrosyl residues in membrane-associated proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973067      PMCID: PMC282512          DOI: 10.1073/pnas.85.22.8628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies.

Authors:  L Lefrançois; M J Bevan
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

2.  Inhibition of T cell responses to alloantigens and polyclonal mitogens by Ly-5 antisera.

Authors:  J A Harp; B S Davis; S J Ewald
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

3.  A rat anti-mouse kappa chain specific monoclonal antibody, 187.1.10: purification, immunochemical properties and its utility as a general second-antibody reagent.

Authors:  C F Ware; J L Reade; L C Der
Journal:  J Immunol Methods       Date:  1984-11-16       Impact factor: 2.303

4.  Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity.

Authors:  W E Seaman; N Talal; L A Herzenberg; L A Herzenberg; J A Ledbetter
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

5.  Selective blockade of human natural killer cells by a monoclonal antibody.

Authors:  W Newman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat.

Authors:  R Dalchau; J Kirkley; J W Fabre
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

8.  Phorbol 12,13-dibutyrate enhances lateral redistribution of membrane glycoproteins in human blood lymphocytes.

Authors:  M Patarroyo; C G Gahmberg
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

9.  On the function of Ly-5 in the regulation of antigen-driven B cell differentiation. Comparison and contrast with Lyb-2.

Authors:  H Yakura; F W Shen; E Bourcet; E A Boyse
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

10.  Identification of a human T lymphocyte surface protein associated with the E-rosette receptor.

Authors:  M Kamoun; P J Martin; J A Hansen; M A Brown; A W Siadak; R C Nowinski
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  65 in total

1.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

2.  Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase.

Authors:  C- L Yu; H-S Yu; K-H Sun; S-C Hsieh; C-Y Tsai
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 3.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

4.  Regulation of CD3-induced phospholipase C-gamma 1 (PLC gamma 1) tyrosine phosphorylation by CD4 and CD45 receptors.

Authors:  S B Kanner; J P Deans; J A Ledbetter
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

5.  A Simple, Versatile Antibody-Based Barcoding Method for Flow Cytometry.

Authors:  Billur Akkaya; Pietro Miozzo; Amanda H Holstein; Ethan M Shevach; Susan K Pierce; Munir Akkaya
Journal:  J Immunol       Date:  2016-07-20       Impact factor: 5.422

6.  Approaches to the molecular cloning of protein-tyrosine phosphatases in insulin-sensitive tissues.

Authors:  B J Goldstein; W R Zhang; N Hashimoto; C R Kahn
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

7.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.

Authors:  G A Koretzky; J Picus; T Schultz; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

8.  Evidence for involvement of glycoprotein-CD45 phosphatase in reversing glycoprotein-CD3-induced microtubule-associated protein-2 kinase activity in Jurkat T-cells.

Authors:  S Pollack; J A Ledbetter; R Katz; K Williams; B Akerley; K Franklin; G Schieven; A E Nel
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

9.  CD4 and CD8 molecules can physically associate with the same T-cell receptor.

Authors:  P F Gallagher; B Fazekas de St Groth; J F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Genetic basis of antigenic differences between three alleles of Ly5 (CD45) in mice.

Authors:  W C Raschke; M Hendricks; C M Chen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.